Literature DB >> 7160422

Pharmacokinetics of meptazinol in man following repeated intramuscular administration.

G Davies, A J Sinclair, S J Warrington, R Franklin, T Frost, A Latham, P J Robson.   

Abstract

A study was performed in 6 healthy volunteers to determine whether 50 mg intramuscular doses of meptazinol repeated four hourly for 24 h would lead to accumulation of the drug. The first dose of meptazinol was rapidly absorbed with a subsequent mean (+/- SD) elimination half-life of 1.6 +/- 0.33 h. This value was unaffected by the administration of intermediate doses. There was no significant accumulation of the drug; 95% of the steady-state plasma concentration was achieved after a mean (+/- SD) of 1.9 +/- 0.39 and 99% after a mean (+/- SD) of 2.9 +/- 0.63 doses. These findings are consistent with the theoretical prediction for a rapidly absorbed drug with a plasma elimination half-life of 1.6 h. No clinically relevant changes were seen in pulse blood pressure, haematological or biochemical screens. Reported side effects were of a subjective and minor nature.

Entities:  

Mesh:

Substances:

Year:  1982        PMID: 7160422     DOI: 10.1007/bf00637502

Source DB:  PubMed          Journal:  Eur J Clin Pharmacol        ISSN: 0031-6970            Impact factor:   2.953


  6 in total

1.  Meptazinol (Wy 22811), a new analgesic: preliminary pharmacokinetic data.

Authors:  M T Rosseel; M G Bogaert; F M Belpaire
Journal:  Curr Med Res Opin       Date:  1975       Impact factor: 2.580

2.  Double-blind comparison of meptazinol and pethidine in labour.

Authors:  A D Nicholas; P J Robson
Journal:  Br J Obstet Gynaecol       Date:  1982-04

3.  Determination of meptazinol in plasma by high-performance liquid chromatography with fluorescence detection.

Authors:  T Frost
Journal:  Analyst       Date:  1981-09       Impact factor: 4.616

4.  Pharmacokinetics and metabolism of the new analgesic meptazinol in rats and patas monkeys.

Authors:  R A Franklin; A Aldridge
Journal:  Xenobiotica       Date:  1976-08       Impact factor: 1.908

5.  Clinical evaluation of meptazinol. a new analgesic, in postoperative pain.

Authors:  N J Paymaster
Journal:  Br J Anaesth       Date:  1976-06       Impact factor: 9.166

6.  A double-blind comparison of meptazinol with pethidine in postoperative pain.

Authors:  A Hedges; P Turner; J Wadsworth
Journal:  Br J Anaesth       Date:  1980-03       Impact factor: 9.166

  6 in total
  2 in total

Review 1.  Meptazinol. A review of its pharmacodynamic and pharmacokinetic properties and therapeutic efficacy.

Authors:  B Holmes; A Ward
Journal:  Drugs       Date:  1985-10       Impact factor: 9.546

2.  Enhanced oral bioavailability of meptazinol in cirrhosis.

Authors:  G G Birnie; G G Thompson; T Murray; G Watkinson; M J Brodie
Journal:  Gut       Date:  1987-03       Impact factor: 23.059

  2 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.